NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) | Biotech Hunter

Enrollment

2,960

Participants

Timeline

Start Date

December 29, 2023

Primary Completion Date

December 30, 2026

Study Completion Date

December 30, 2026

Conditions

PregnancyMalariaNutritionPlacental DevelopmentPreterm BirthFetal Growth Restriction

Interventions

DIETARY_SUPPLEMENT

L-citrulline

Twice daily 6.0 g sachet, each containing 5.00 g of quality-assured L-citrulline powder, 0.66 g maltodextrin and 0.30 g lactose anhydrous, 0.03 g citric acid, 0.01 g lemon flavour + antenatal standard of care with enhanced monitoring

Trial Locations (1)

Unknown

RECRUITING

KEMRI Centre for Global Health Research, Kisumu